Get the Stockscreener App
30.12
5.09%
1.46
After Hours:
30.00
-0.12
-0.40%
Sanara Medtech Inc stock is traded at $30.12, with a volume of 6,488.
It is up +5.09% in the last 24 hours and down -10.36% over the past month.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
See More
Previous Close:
$28.66
Open:
$29.5
24h Volume:
6,488
Relative Volume:
0.25
Market Cap:
$261.54M
Revenue:
$64.99M
Net Income/Loss:
$-4.30M
P/E Ratio:
-57.92
EPS:
-0.52
Net Cash Flow:
$-3.51M
1W Performance:
+2.52%
1M Performance:
-10.36%
6M Performance:
-10.81%
1Y Performance:
-8.45%
1-Day Range:
$29.19
$30.12
1-Week Range:
$27.36
$30.12
52-Week Range:
$25.86
$39.08
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech Inc
Sector
Industry
Phone
817-529-2300
Address
1200 SUMMIT AVE, FORT WORTH
Compare SMTI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
30.12 | 261.54M | 64.99M | -4.30M | -3.51M | -0.52 |
|
ISRG
Intuitive Surgical Inc
|
478.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
199.88 | 57.39B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
93.31 | 45.22B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
214.08 | 31.43B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.79 | 15.89B | 3.90B | 392.30M | 288.10M | 1.95 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-26-25 | Reiterated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Stock (SMTI) Latest News
Sanara MedTech to Present at Investor Showcase - TipRanks
How To Trade (SMTI) - news.stocktradersdaily.com
Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 - marketscreener.com
Medical Technology Leader Sanara MedTech Unveils Growth Strategy at Major Vegas Investor Event - Stock Titan
Sanara MedTech (SMTI) Stock Jumps 8.1%: Will It Continue to Soar? - Nasdaq
Sanara MedTech stock hits 52-week low at $25.9 amid challenges By Investing.com - Investing.com South Africa
Sanara MedTech stock hits 52-week low at $25.9 amid challenges - Investing.com Australia
How to Take Advantage of moves in (SMTI) - news.stocktradersdaily.com
Sanara MedTech Inc. Announces Second Quarter 2021 Results and Business Update - ACCESS Newswire
Q1 EPS Estimates for Sanara MedTech Reduced by HC Wainwright - MarketBeat
Cantor Fitzgerald Predicts Sanara MedTech FY2025 Earnings - MarketBeat
Cantor Fitzgerald Reaffirms Overweight Rating for Sanara MedTech (NASDAQ:SMTI) - MarketBeat
Sanara MedTech Inc. (NASDAQ:SMTI) Q4 2024 Earnings Call Transcript - Insider Monkey
HC Wainwright Reduces Earnings Estimates for Sanara MedTech - Defense World
Bank of New York Mellon Corp Purchases 2,528 Shares of Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Sanara MedTech (NASDAQ:SMTI) Releases Quarterly Earnings Results - MarketBeat
FY2025 EPS Estimate for Sanara MedTech Decreased by Analyst - Defense World
Sanara MedTech (NASDAQ:SMTI) Earns Overweight Rating from Cantor Fitzgerald - Defense World
Sanara MedTech targets pilot launch of Tissue Health Plus in Q2 2025 - MSN
Sanara MedTech (NASDAQ:SMTI) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
HC Wainwright Issues Positive Forecast for Sanara MedTech (NASDAQ:SMTI) Stock Price - Defense World
Cantor maintains $46 target on Sanara MedTech stock By Investing.com - Investing.com Canada
Where Sanara MedTech Stands With AnalystsSanara MedTech (NASDAQ:SMTI) - Benzinga
Sanara Medtech Inc (NASDAQ:SMTI) Liquidity Decreases - FXDailyReport.com
Sanara MedTech stock target raised to $51 by H.C. Wainwright - Investing.com UK
Cantor maintains $46 target on Sanara MedTech stock - Investing.com
Sanara MedTech reports net loss of USD 1.7M in Q4 2024 - Medical Buyer
Sanara MedTech Inc (SMTI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
Sanara MedTech Inc (SMTI) Q4 2024 Earnings Call Highlights: Stro - GuruFocus
Sanara MedTech Reports Strong Revenue Growth in 2024 - TipRanks
Sanara MedTech Inc. (SMTI) reports earnings - Quartz
Sanara MedTech Inc Reports Q4 2024 Revenue of $26.3M, Beating Es - GuruFocus
Sanara MedTech Inc (SMTI) Shares Gap Down to $32.1 on Mar 25 - GuruFocus.com
Sanara Medtech earnings beat by $0.16, revenue topped estimates - Investing.com UK
Sanara Medtech Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Sanara Medtech Q4 2024 shows strong growth By Investing.com - Investing.com South Africa
Earnings call transcript: Sanara Medtech Q4 2024 shows strong growth - Investing.com
Sanara MedTech Inc. Q4 Loss Climbs - Nasdaq
Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited) - GlobeNewswire
Earnings To Watch: Sanara MedTech Inc (SMTI) Reports Q4 2024 Res - GuruFocus
Sanara Medtech Inc expected to post a loss of 11 cents a shareEarnings Preview - TradingView
Sanara MedTech (SMTI) to Release Quarterly Earnings on Monday - MarketBeat
Sanara MedTech (SMTI) Projected to Post Quarterly Earnings on Monday - Defense World
When (SMTI) Moves Investors should Listen - Stock Traders Daily
Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - The Manila Times
Sanara MedTech to Unveil Full Year 2024 Performance: Key Earnings Call Details Inside - StockTitan
Sanara Medtech Inc Stock (SMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):